As of Feb 20, 2024, Apple Relative Value is $46.2. This suggests it may be overvalued by 462.4% compared to its current price of around $8.2.
As of Feb 20, 2024, Bright Health Group, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $8.2, using a discount rate of 3.9% and terminal growth rate of 3.0%.
As of Feb 20, 2024, Apple Intrinsic Value is $46.2. This suggests it may be undervalued by 463.3% compared to its current price of around $8.2.